Incubate Coalition

WASHINGTON (January 28)  -- Yesterday, the Centers for Medicare & Medicaid Services announced  the third round of drugs subject to Medicare price controls under the Inflation Reduction Act. The new government-set prices will affect medicines covered under both Medicare Part D and Medicare Part B and take effect in 2028.   Incubate's executive director, John Stanford, issued the following statement in response:   "The latest announcement from CMS represents a significant expansion of the...